O
Osvaldo Massaiti Takayanagui
Researcher at University of São Paulo
Publications - 132
Citations - 4839
Osvaldo Massaiti Takayanagui is an academic researcher from University of São Paulo. The author has contributed to research in topics: Neurocysticercosis & Cysticercosis. The author has an hindex of 34, co-authored 128 publications receiving 4428 citations.
Papers
More filters
Journal ArticleDOI
Proposed diagnostic criteria for neurocysticercosis
O. H. Del Brutto,Vedantam Rajshekhar,A. C. White,Victor C. W. Tsang,Theodore E. Nash,Osvaldo Massaiti Takayanagui,P.M. Schantz,Carlton A. Evans,Ana Flisser,Dolores Correa,D. Botero,J. C. Allan,Elsa Sarti,Armando E. Gonzalez,Robert H. Gilman,Robert H. Gilman,Hector H. Garcia +16 more
TL;DR: Diagnosis of neurocysticercosis is provided based on objective clinical, imaging, immunologic, and epidemiologic data and Interpretation permits two degrees of diagnostic certainty.
Journal ArticleDOI
Current Consensus Guidelines for Treatment of Neurocysticercosis
Hector H. Garcia,Carlton A. Evans,Carlton A. Evans,Theodore E. Nash,Osvaldo Massaiti Takayanagui,A. Clinton White,David Botero,Vedantam Rajshekhar,Victor C. W. Tsang,Peter M. Schantz,J. C. Allan,Ana Flisser,Dolores Correa,Elsa Sarti,Jon S. Friedland,S. Manuel Martinez,Armando E. Gonzalez,Robert H. Gilman,Robert H. Gilman,Oscar H. Del Brutto +19 more
TL;DR: Overall, four general recommendations were made: individualize therapeutic decisions, including whether to use antiparasitic drugs, based on the number, location, and viability of the parasites within the nervous system.
Journal ArticleDOI
Proposal for diagnostic criteria of tropical spastic paraparesis/HTLV-I-associated myelopathy (TSP/HAM)
Carlos Maurício de Castro-Costa,Abelardo Q.C. Araújo,Márcio M. Barreto,Osvaldo Massaiti Takayanagui,Marzia P. Sohler,Eduardo L. M. Da Silva,Sônia M. B. De Paula,Ricardo Ishak,João G. R. Ribas,Luis C. Rovirosa,Herwig Carton,Eduardo Gotuzzo,William W. Hall,Silvia M. Montano,Edward L. Murphy,Joel Oger,Carlos Remondegui,Graham P. Taylor +17 more
TL;DR: Brazilian neurologists and observers from other countries met recently to discuss and propose a modified model for diagnosing TSP/HAM with levels of ascertainment as definite, probable, and possible, according to myelopathic symptoms, serological findings, and/or detection of HTLV-I DNA and exclusion of other disorders.
Journal ArticleDOI
Calcific neurocysticercosis and epileptogenesis
Theodore E. Nash,O. H. Del Brutto,John A. Butman,T. Corona,Antonio V. Delgado-Escueta,Reyna M. Durón,Carlton A. Evans,Robert H. Gilman,Robert H. Gilman,Armando E. Gonzalez,Jeffrey A. Loeb,Marco T. Medina,S. Pietsch-Escueta,E. J. Pretell,Osvaldo Massaiti Takayanagui,William H. Theodore,Victor C. W. Tsang,Hector H. Garcia,Hector H. Garcia +18 more
TL;DR: A better understanding of the natural history, frequency, epidemiology, and pathophysiology of calcific cysticercosis and associated disease manifestations is needed to define its importance, treatment, and prevention.
Journal ArticleDOI
Therapy for Neurocysticercosis: Comparison Between Albendazole and Praziquantel
TL;DR: Albendazole was significantly more effective than praziquantel in reducing the total number of cysts in the computed tomographic scans and Considering the risks and fallibility of anticysticercal therapy, the real solution for this serious disease continues to be prophylaxis of infestation.